title: Comment on Lipsky et al.: Incidence and Risk Factors of Bleeding-Related Adverse Events in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib.
authors.affiliation: Department of Haematology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia University of Melbourne, St Vincent's Hospital, Melbourne, Victoria, Australia constantine.tam@petermac.org.
authors.forename: Constantine S
authors.initials: CS
authors.lastname: Tam
authors.affiliation: Department of Haematology, St Vincent's Hospital, Melbourne, Victoria, Australia.
authors.forename: Sarah
authors.initials: S
authors.lastname: Kamel
mesh_terms: D006470:Hemorrhage; D006801:Humans; D015994:Incidence; D015451:Leukemia, Lymphocytic, Chronic, B-Cell; D012307:Risk Factors
keywords: chronic lymphocytic leukemia; lymphocytes; platelets